Newron Pharmaceuticals SpA (NWRN) — Cash Flow Quality Index
Newron Pharmaceuticals SpA (NWRN) has a Cash Flow Quality Index of -0.28x as of December 2024. Operating cash flow of CHF-8.79 Million is below net income of CHF30.95 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Newron Pharmaceuticals SpA long-term investment allocation to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Newron Pharmaceuticals SpA Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Newron Pharmaceuticals SpA across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Newron Pharmaceuticals SpA (NWRN) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Newron Pharmaceuticals SpA (2024–2024)
Year-by-year earnings quality comparison for Newron Pharmaceuticals SpA. For live market cap and the full company financial profile, see market value of Newron Pharmaceuticals SpA.
| Year | Quality Index | Operating CF (CHF) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.82x | CHF-17.61 Million | CHF21.39 Million | — |